Technology

Over the next year and a half, Commonwealth Fusion Systems is building a $300-million, 47-acre headquarters in Devens, in its $1-billion, long-term effort to make fusion the default energy source on Earth

Central Massachusetts professionals are taking new jobs and getting promoted at companies like Estate Preservation Law Offices, Avidia Bank, AdCare Hospital and Banjo Health.

Akoya Biosciences, a Marlborough firm analyzing tissues for therapy research, announced increases in revenue and  profits in the first quarter, along with plans to continue hiring new employees.

Newmine, a developer of retail returns reduction platform, has named Trishan Singh as its new chief technology officer.

A chemistry professor at the College of the Holy Cross in Worcester has been awarded more than $400,000 from the National Science Foundation to study how molecules mix with each other. 

Marlborough drugmaker Phio Pharmaceuticals has ended the first quarter with $32.7 million in cash on hand, amid climbing losses due to increased research and development of its cancer-therapy technology.

Kris Canekeratne, the founder of Southborough IT company Virtusa Corp., will leave his roles as chairman and CEO by June 30, an announcement which follows his company being acquired for $2 billion by financial services firm Baring Private Equity Asia.

UMass Memorial Health of Worcester announced on Tuesday it helped create a new TeamBirth partnership with Wellesley insurer Harvard Pilgrim Health Care and Boston health center Ariadne Labs to launch a new initiative at the UMass hospitals in Leominster and Worcester, aimed at improving maternal health and birth outcomes.

A team of researchers including Worcester Polytechnic Institute Biology Professor Pamela Weathers has found that extracts from a medicinal herb known as sweet wormwood can inhibit the COVID-19 virus and two of its recent variants.

The Framingham pharmaceutical firm Alzheon has partnered with the Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences to develop a diagnostic assay to measure substances believed to be neurotoxic drivers of Alzheimer’s disease pathology.